LifeStance Health Group (NASDAQ:LFST) Price Target Raised to $15.00

by · The Markets Daily

LifeStance Health Group (NASDAQ:LFST – Free Report) had its price objective upped by BTIG Research from $12.00 to $15.00 in a report released on Friday,Benzinga reports. BTIG Research currently has a buy rating on the stock.

A number of other brokerages have also recently commented on LFST. Weiss Ratings reiterated a “hold (c-)” rating on shares of LifeStance Health Group in a research note on Wednesday, May 27th. KeyCorp upped their target price on LifeStance Health Group from $11.00 to $13.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. JPMorgan Chase & Co. increased their target price on LifeStance Health Group from $8.00 to $9.00 and gave the company a “neutral” rating in a research report on Thursday, May 14th. Wall Street Zen raised LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Finally, Canaccord Genuity Group upped their price objective on LifeStance Health Group from $11.00 to $13.00 and gave the company a “buy” rating in a research note on Tuesday, July 21st. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $11.50.

Get Our Latest Analysis on LifeStance Health Group

LifeStance Health Group Price Performance

Shares of NASDAQ LFST opened at $10.90 on Friday. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.18. The company has a market cap of $4.23 billion, a price-to-earnings ratio of 181.67 and a beta of 1.12. LifeStance Health Group has a 12 month low of $3.74 and a 12 month high of $11.76. The stock has a 50-day moving average price of $9.33 and a two-hundred day moving average price of $7.82.

LifeStance Health Group (NASDAQ:LFST – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.03. LifeStance Health Group had a net margin of 1.55% and a return on equity of 1.56%. The company had revenue of $403.48 million for the quarter, compared to analyst estimates of $387.46 million. LifeStance Health Group’s revenue for the quarter was up 21.2% compared to the same quarter last year. As a group, analysts forecast that LifeStance Health Group will post 0.12 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other LifeStance Health Group news, Director Darren M. Black sold 5,899,661 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total value of $47,315,281.22. Following the sale, the director owned 23,310,115 shares in the company, valued at approximately $186,947,122.30. The trade was a 20.20% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Eric Shuey sold 243,362 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $8.02, for a total value of $1,951,763.24. Following the completion of the sale, the director directly owned 867,562 shares of the company’s stock, valued at approximately $6,957,847.24. The trade was a 21.91% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 7,687,394 shares of company stock valued at $63,579,701. 3.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Larson Financial Group LLC boosted its stake in shares of LifeStance Health Group by 19,952.6% in the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock valued at $27,000 after purchasing an additional 3,791 shares during the last quarter. KBC Group NV bought a new position in LifeStance Health Group during the first quarter worth $29,000. EverSource Wealth Advisors LLC lifted its holdings in LifeStance Health Group by 359.1% in the first quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock valued at $44,000 after buying an additional 5,404 shares during the period. PNC Financial Services Group Inc. lifted its holdings in LifeStance Health Group by 615.3% in the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after buying an additional 7,987 shares during the period. Finally, Assetmark Inc. boosted its position in LifeStance Health Group by 17.0% during the first quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock valued at $60,000 after acquiring an additional 1,367 shares during the last quarter. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

(Get Free Report)

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.

Read More